Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

268 results

Stibbe advises SleepScore Labs

Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.

Stibbe advises Lundbeck

Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.

Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe

Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Stibbe advises Aedifica

Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands.

Anya Murphy

Junior Associate Brussels

Stibbe advises pharmaceutical multinational

Stibbe assisted a pharmaceutical multinational in complex litigations.

Stibbe represents retail company

Stibbe represented an upmarket department store company in the highly publicized proceedings before Belgium’s Supreme Court (Hof van Cassatie/Cour de cassation) regarding the validity of the national sales period legislation in light of EU law.

Stibbe advises KBC Securities

Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.

Mini-symposium “De accountant – Paard van Troje?”

Op dinsdag 21 mei organiseert de afdeling Corporate Criminal Law & Investigations van Stibbe een mini-symposium rond het thema van de accountant als pseudo-opsporingsambtenaar en de controlecliënt als potentiële verdachte.

Stibbe advises worldwide seeds leader

Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.

Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective”

Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.

HagaZiekenhuis beboet voor datalek

Enkele maanden geleden vierden we de eerste verjaardag van de Algemene Verordening Gegevensbescherming (AVG) met een uitgebreide beschouwing  over de belangrijkste  ontwikkelingen uit  het eerste jaar van de verordening.

Stibbe represents the bankruptcy trustees of Amsterdam hospital MC Slotervaart in dispute with the City of Amsterdam

Stibbe represented the bankruptcy trustees of  the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban

Abuse of economic dependence and unfair contract terms in B2B relations: ready for 2020?

Belgium adopted a new act prohibiting the abuse of economic dependence, the use of unfair contract terms and unfair market practices in B2B relationships.

Stibbe advises DW Healthcare Partners

Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.

Acrylamide: zijn frieten ook juridisch schadelijk voor de gezondheid?

De risico’s door de aanwezigheid van acrylamide in levensmiddelen noopten de EU tot het nemen van risicobeperkende maatregelen.

Does selling a phone on an online marketplace make you a "trader" under the Unfair Commercial Practices Directive and the Consumer Rights Directive?

Online marketplaces provide sales channels not only for professional traders but also for individuals selling second-hand goods. For buyers, online advertisements do not always make it clear whether the seller is a professional trader or an individual.

Stakingsrechter onbevoegd bij omzeiling specifieke verhaalsinstanties in bijzondere wetgeving

Bij arrest van 17 oktober 2018 stelde het Hof van Beroep te Brussel een belangrijke grens aan de ongebreidelde mogelijkheid tot instellen van een stakingsvordering.

Pagination

  • Previous page
  • Page 10
  • Current page 11
  • Page 12
  • Page 13
  • Next page
Reset filters
Date
Content type
  • Article (172)
  • Event (2)
  • Inside Stibbe (2)
  • Matter (64)
  • Podcast (3)
  • People (25)
Expertise
  • (-) Healthcare and Life Sciences (85)
  • (-) Unfair Competition and Consumer Protection (186)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (428)
  • Capital Markets (247)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (862)
  • Corporate Investigations (31)
  • Criminal Law and Enforcement (142)
  • Digital Economy (108)
  • Employment, Benefits and Pensions (409)
  • Energy, Industry and Climate (311)
  • Environment and Planning (878)
  • ESG & Sustainability (295)
  • EU and Competition Law (492)
  • Financial Regulation (172)
  • Infrastructure and Mobility (192)
  • Insurance (36)
  • Intellectual Property (120)
  • Investment Funds (141)
  • Litigation and Arbitration (426)
  • Privacy and Data Protection (202)
  • Private Equity (197)
  • Procurement Law (122)
  • Public Law (1187)
  • Real Estate (469)
  • Restructuring and Insolvency (116)
  • Sports (25)
  • Stibbe StartsUP (29)
  • Tax (444)
  • Technology, Media and Telecommunications (330)
Jurisdiction
  • BE Law (149)
  • EU Law (86)
  • LU Law (7)
  • NL Law (53)
Language
  • Dutch (83)
  • English (117)
  • French (68)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information